Sponsor pipeline

Chengdu Kangnuoxing Biopharma,Inc. clinical trial pipeline

Get alerts when Chengdu Kangnuoxing Biopharma,Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
1
Phase 3
2
Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07678931 Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis Seasonal Allergic Rhinitis (SAR) Recruiting 2026-09-03
NCT07210554 Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid Bullous Pemphigoid (BP) Not Yet Recruiting 2025-10-07
Phase 2
NCT07617324 Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis… Seasonal Allergic Rhinitis (SAR) Not Yet Recruiting 2026-06-01
Not specified
NCT07544862 A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD) Atopic Dermatitis (AD) Recruiting 2026-06-10
NCT07483268 A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal… CRSWNP Active, Not Recruiting 2026-06-05
NCT07459556 A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis… SAR Not Yet Recruiting 2026-03-09

Disease areas by active trials

Atopic Dermatitis (1)

Get alerts when Chengdu Kangnuoxing Biopharma,Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free